Lonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid Laminopathy

首次发布于 2019 年 3 月 29 日

Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid

计划入组 15 人 · 首次发布于 2008 年 8 月 8 日

Umbilical Cord Blood Transfusion in Progeria Syndrome

计划入组 2 人 · 首次发布于 2019 年 3 月 12 日

icmt inhibitors (cancer/Hutchinson Gilford progeria syndrome)

Lonafarnib(Zokinvy)

C₂₇H₃₁Br₂ClN₄O₂

CTL (Fred Hutchinson)

ALPORT SYNDROME FOUNDATION

United States

FRED HUTCHINSON CANCER CENTER

United States

International Rett Syndrome Foundation

United States

Sentynl Therapeutics Licenses Progerinin for Hutchinson-Gilford Progeria Syndrome Treatment

Biologics by McKesson Selected as Exclusive Pharmacy for Progeria Drug ZOKINVY

FDA Authorizes Phase 2a Trial of Progerinin for Hutchinson-Gilford Progeria Syndrome